Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Rakovina Therapeutics Inc. announced its participation in the 13th Annual Tumour Models London Summit, where it will showcase its innovative cancer treatment research. Prof. Mads Daugaard, the company’s president, will present the development of 3D bioprinted bone mimics for drug screening and cancer research. The summit is a platform for sharing advanced insights into drug discovery and cancer therapy.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.
